|
Market Cap | 65.93M | EPS (ttm) | -1.00 |
P/E | - | EPS this Y | -661.90% |
Forward P/E | - | EPS next Y | 1.69% |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -42448.15% |
Dividend | - | Sales Q/Q | - |
Insider Own | 70.48% | Inst Own | 13.30% |
Insider Trans | 0.00% | Inst Trans | 4.36% |
Short Float | 3.78% | Earnings | Mar 29/a |
Analyst Recom | 1.00 | Target Price | 18.00 |
Avg Volume | 70.02K | 52W Range | 3.24 - 17.17 |
|
|
|
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Strathspey Crown Holdings Grou | 10% Owner | Aug 11 '23 | Sale | 10.00 | 7,380,394 | 73,803,940 | 2,031,773 | Aug 14 04:10 PM |
|
|
|
|
Market Cap | 25.48M | EPS (ttm) | -0.36 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 1.88 | EPS Q/Q | -116.00% |
Dividend | - | Sales Q/Q | - |
Insider Own | 76.28% | Inst Own | 23.53% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.53% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 100.16K | 52W Range | 4.04 - 21.50 |
|
|
Holdco Nuvo Group DG Ltd. engages in the provision of pregnancy care. The company was founded on July 20, 2023 and is headquartered in Tel Aviv, Israel. |
|
|
|
Market Cap | 115.26M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 53.46% | Inst Own | - |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.30% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 7.00 |
Avg Volume | 5.14M | 52W Range | 4.79 - 29.50 |
|
|
|
Mobile-health Network Solutions operates as an investment holding company. The company through its subsidiaries provides telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribed and delivered with the medication at their doorsteps. The company's segments include: Telemedicine and Other Services, and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore. |
|
| |
|
Market Cap | 1.82M | EPS (ttm) | 19522.27 |
P/E | 0.00 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 85.56% |
P/S | 0.03 | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.27% | Inst Own | 1.68% |
Insider Trans | 0.00% | Inst Trans | -1.85% |
Short Float | 1.45% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 143.00K | 52W Range | 0.50 - 60.00 |
|
|
|
FLJ Group Ltd. engages in the operation of a technology-driven apartment rental platform. It offers affordable branded apartments as well as facilitates a variety of value-added services. The company was founded in 2012 by Guang Jie Jin and is headquartered in Shanghai, China. |
|
|
|
Market Cap | 1.63B | EPS (ttm) | -1.25 |
P/E | - | EPS this Y | 220.41% |
Forward P/E | 40.19 | EPS next Y | 59.87% |
PEG | - | EPS past 5Y | -22.91% |
P/S | 4.59 | EPS next 5Y | - |
P/B | 11.06 | EPS Q/Q | -29.66% |
Dividend | - | Sales Q/Q | 28.68% |
Insider Own | 14.84% | Inst Own | 108.50% |
Insider Trans | -5.41% | Inst Trans | 0.38% |
Short Float | 18.23% | Earnings | May 02/a |
Analyst Recom | 2.07 | Target Price | 49.36 |
Avg Volume | 638.03K | 52W Range | 37.00 - 68.41 |
|
|
May-03-24 | Downgrade |
BTIG Research |
Buy → Neutral |
|
May-03-24 | Downgrade |
Piper Sandler |
Overweight → Neutral |
$66 → $40 |
May-03-24 | Downgrade |
Robert W. Baird |
Outperform → Neutral |
$72 → $45 |
May-03-24 | Downgrade |
KeyBanc Capital Markets |
Overweight → Sector Weight |
|
May-03-24 | Downgrade |
Goldman |
Buy → Neutral |
$80 → $44 |
May-03-24 | Downgrade |
William Blair |
Outperform → Mkt Perform |
|
|
|
Sprout Social, Inc. provides online social media management tools for businesses. It offers communication tools, contact management, lead generation, and analytics services. The firm also offers solutions for enterprises, agencies, small businesses, customer service, social media marketing, and employee advocacy sectors. The company was founded by Justyn Howard, Aaron Rankin, Gilbert Lara, and Peter Soung in 2010 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Howard Justyn Russell | Chairman and CEO | Apr 08 '24 | Sale | 56.52 | 20,000 | 1,130,325 | 0 | Apr 09 05:28 PM | Rankin Aaron Edward Frederick | Director | Apr 04 '24 | Sale | 56.95 | 22,000 | 1,252,800 | 0 | Apr 08 05:29 PM | Barretto Ryan Paul | President | Apr 04 '24 | Sale | 56.95 | 5,600 | 318,936 | 198,175 | Apr 08 05:30 PM | Del Preto Joseph | CFO and Treasurer | Apr 01 '24 | Sale | 59.63 | 1,500 | 89,445 | 172,644 | Apr 02 05:30 PM | Howard Justyn Russell | Chairman and CEO | Mar 07 '24 | Sale | 58.36 | 40,000 | 2,334,530 | 0 | Mar 08 04:04 PM |
|
|
| |
|
Market Cap | 1.00B | EPS (ttm) | 0.09 |
P/E | 45.57 | EPS this Y | -3.81% |
Forward P/E | 12.71 | EPS next Y | 62.38% |
PEG | 2.36 | EPS past 5Y | - |
P/S | 0.55 | EPS next 5Y | 19.30% |
P/B | 1.12 | EPS Q/Q | -206.62% |
Dividend | - | Sales Q/Q | -9.04% |
Insider Own | 77.33% | Inst Own | 18.72% |
Insider Trans | 0.03% | Inst Trans | 0.07% |
Short Float | 4.46% | Earnings | May 02/a |
Analyst Recom | 1.60 | Target Price | 7.80 |
Avg Volume | 555.62K | 52W Range | 4.41 - 7.53 |
|
|
|
Custom Truck One Source, Inc. engages in the sale and rental of truck and heavy equipment. The firm offers aftermarket parts and service, equipment customization, remanufacturing, financing solutions, and asset disposal services. The company was founded in 1996 and is headquartered in Kansas City, MO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Eperjesy Christopher J | Chief Financial Officer | Apr 01 '24 | Option Exercise | 0.00 | 67,500 | 0 | 179,442 | Apr 03 04:37 PM | Carlsen James | CIO | Apr 01 '24 | Option Exercise | 0.00 | 22,500 | 0 | 85,801 | Apr 03 04:38 PM | Ross Fredrick M. Jr. | Director | Apr 01 '24 | Option Exercise | 0.00 | 175,000 | 0 | 356,777 | Apr 03 04:38 PM | Rich Thomas R. | President - Rentals | Apr 01 '24 | Option Exercise | 0.00 | 100,000 | 0 | 242,729 | Apr 03 04:41 PM | BARRETT RAYMOND TODD | Chief Accounting Officer | Apr 01 '24 | Option Exercise | 0.00 | 15,000 | 0 | 41,575 | Apr 03 04:41 PM |
|
|
|
|
Market Cap | 5.12M | EPS (ttm) | -12.68 |
P/E | - | EPS this Y | 54.77% |
Forward P/E | - | EPS next Y | 4.66% |
PEG | - | EPS past 5Y | -13.86% |
P/S | - | EPS next 5Y | - |
P/B | 0.50 | EPS Q/Q | 60.48% |
Dividend | - | Sales Q/Q | - |
Insider Own | 1.74% | Inst Own | 15.24% |
Insider Trans | 0.00% | Inst Trans | 9.29% |
Short Float | 2.81% | Earnings | Mar 28/a |
Analyst Recom | 1.00 | Target Price | 24.50 |
Avg Volume | 34.90K | 52W Range | 2.45 - 21.25 |
|
|
|
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CARLSON CAPITAL L P | 10% Owner | Aug 16 '23 | Sale | 0.39 | 1,000 | 392 | 5,064,000 | Aug 17 05:29 PM | Weisman Harlan F | President and CEO | Aug 15 '23 | Buy | 0.25 | 600,000 | 150,000 | 814,615 | Aug 15 08:00 AM | Mikhak Zamaneh | Chief Medical Officer | Aug 15 '23 | Buy | 0.25 | 120,000 | 30,000 | 135,000 | Aug 15 08:00 AM | MILLS ROBERT S | Director | Aug 15 '23 | Buy | 0.25 | 40,000 | 10,000 | 55,980 | Aug 15 08:00 AM | ROCAMBOLI STEPHEN | Director | Aug 15 '23 | Buy | 0.25 | 20,000 | 5,000 | 36,000 | Aug 15 08:00 AM |
|
|
| |
|
Market Cap | 5.98M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -7.52% |
Dividend | - | Sales Q/Q | - |
Insider Own | 55.56% | Inst Own | 4.46% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.57% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 58.46K | 52W Range | 2.24 - 200.00 |
|
|
|
Zapp Electric Vehicles Group Ltd. designs, manufactures and sells electric vehicles. It offers maintenance and repair of motorcycles and related parts and accessories. The company was founded by Swin Chatsuwan, Jeremy North, Warin Thanathawee and Kiattipong Arttachariya in 2017 and is headquartered in London, the United Kingdom. |
|
|
|
Market Cap | 2.39M | EPS (ttm) | -4117.54 |
P/E | - | EPS this Y | 98.73% |
Forward P/E | - | EPS next Y | 40.00% |
PEG | - | EPS past 5Y | 57.56% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 99.91% |
Dividend | - | Sales Q/Q | - |
Insider Own | 10.59% | Inst Own | 0.12% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 4.93% | Earnings | Mar 08/b |
Analyst Recom | 1.00 | Target Price | 8.00 |
Avg Volume | 2.07M | 52W Range | 1.14 - 372.00 |
|
|
|
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA. |
|
|
|
Market Cap | 2.28M | EPS (ttm) | -11.00 |
P/E | - | EPS this Y | 90.10% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.67 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 8.14% | Inst Own | 1.60% |
Insider Trans | -0.30% | Inst Trans | - |
Short Float | 9.25% | Earnings | - |
Analyst Recom | - | Target Price | 3.00 |
Avg Volume | 2.48M | 52W Range | 0.31 - 29.75 |
|
|
|
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rome Zachary | Director | Jan 29 '24 | Sale | 0.48 | 811 | 389 | 15,148 | Jan 31 07:55 PM | Weisman Howard J. | Chief Executive Officer | Jan 29 '24 | Sale | 0.47 | 372 | 175 | 37,675 | Jan 31 05:16 PM | LaRochelle Karen | Director | Jan 29 '24 | Sale | 0.48 | 78 | 37 | 2,829 | Jan 31 05:19 PM | Coelho John F | Director | Jan 29 '24 | Sale | 0.48 | 27 | 13 | 4,615 | Jan 31 05:18 PM | Rome Zachary | Director | Nov 27 '23 | Sale | 1.03 | 359 | 370 | 15,959 | Nov 29 04:07 PM |
|
|
|